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Long-term in vivo carcinogenicity tests of potassium bromate (KBrO3), sodium hypochlorite (NaClO),
and sodium chlorite (NaClO2) have been conducted in Japan from 1977 to 1985. In these investigations,
groups of approximately 50 male and 50 female F344 rats or B6C3F1 mice were given solutions of the
compounds as their drinking water ad libitum at two dose levels determined on the basis of preliminary
13-week tests. Control animals were given distilled water.
The carcinogenic potential of KBrO3 was tested by administering doses of 500 or 250 ppm to rats for
110 weeks. Significantly elevated incidences ofrenal cell tumors in males and females and mesotheliomas
of the peritoneum in males as compared to controls were observed. When female mice were given KBrO3
at doses of 1000 or 500 ppm for 78 weeks, no significant differences in tumor incidences between experi-
mental and control groups were apparent.
NaClO was administered to male and female rats, respectively, at doses of 1000 or 500 ppm and 2000 or
1000 ppm for 104 weeks. In mice, NaClO was given at doses of 1000 or 500 ppm to either sex for 103 weeks.
The incidences of tumors in NaClO-treated and control animals of both sexes were not significantly
different in both rat and mouse studies.
NaClO2was given torats ofboth sexes atadose of600or300ppmfor85weeks. No statistically significant
differences were observed inthe incidences oftumorformation between NaCI02-treated andcontrol groups
of both sexes. NaCI02 was administered to mice at a concentration of 500 or 250 ppm for 85 weeks. In
males, the combined incidences of hyperplastic nodules and hepatocellular carcinomas of the liver in a
low-dose group, and adenomas and adenocarcinomas of the lung in a high-dose group, were marginally
increased compared tocontrols (p<0.05). However, these incidences intreated maleswerewithintherange
of values of historical control data in our program.
We concluded that KBrO3 was carcinogenic in rats ofboth sexes. NaClO was not carcinogenic in either
rats and or mice under the conditions of the present studies. Although NaClO2 was shown to be noncar-
cinogenic in rats, the results for mice were evaluated as inconclusive. Also the results oftwo-stage mouse
skin carcinogenesis using KBrO3, NaClO, and NaCl02 are presented. The necessity for further testing of
oxidant chemicals to determine potential carcinogenic and/or promoting effects is suggested in view of
the recently proposed role of active oxygen species in carcinogenesis.
Introduction
The cooperative program in Japan for long-term as-
says ofcarcinogenicity was begunin 1974 with asubsidy
for cancer research from the Ministry of Health and
Welfare of Japan (1,2). The primary purpose of these
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studies was not only to test the carcinogenic activity of
environmental chemicals, but also to establish a cor-
relation between the results in long- and short-term
tests. The compounds were chosen for assessing car-
cinogenic potential based on their degree ofhuman ex-
posure, amount ofproduction and use, strength of mu-
tagenicity, previous data on carcinogenicity, etc. To
date, 85 long-term in vivo tests using rats and/or mice
have been conducted on 51 chemicals, including medical
drugs, pesticides, and food additives (Y. Hayashi, un-
published data). In this paper, the results of the car-
cinogenicity bioassays of potassium bromate (KBrO3),
sodium hypochlorite (NaCIO), and sodium chlorite
(NaCI02), which were performed in both rats and miceKUROKAWA ET AL.
wooks
FIGURE 1. Growth curves for male and female rats given KBrO3.
as a part of this program from 1977 to 1985, are pre-
sented. Most ofthe carcinogenicity data described here
are as yetunpublished because the testshave been com-
pleted only very recently.
Materials and Methods
Compounds and Sources
Potassium bromate, KBrO3 (CAS.7758-01-2), is used
as a bread- and flour-improving agent. It was acquired
from Matsunaga Chemical Industry Ltd., Hiroshima,
at a purity of 99.5%.
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FIGURE 2. Survival curves for male and female rats given KBrO3.
FIGURE 3. Low power view of adenocarcinoma of the kidney in a
rat given KBrO,3.
Sodiumhypochlorite, NaClO(CAS.7681-52-9), isused
as a disinfectant and bleaching agent. It was acquired
from Thurumi Soda Co. Ltd., Tokyo. The effective con-
centration of chlorine was 14%.
Sodium chlorite, NaClO2 (CAS.7758-19-2), is used as
a bleaching agent. It was acquired from Wako Pure
Chemical Industries Ltd., Osaka, at a purity of99.4%.
Protocol for Carcinogenicity Testing
The experimental design of the long-term carcino-
genicity tests was essentially similar to that published
in the guidelines of the National Cancer Institute (3).
Details are described in the bioassay of KBrO3 in rats
(4).
Thetest animalsused were4-to6-week-old F344rats
or B6C3F1 mice (specific-pathogen-free) ofboth sexes,
purchased from Charles River Japan Inc., Kanagawa.
Groups ofapproximately 50 male and 50 female rats or
mice were treated with the maximum tolerated dose
(MTD) or 1/2 MTD, determined on the basis of 13-week
toxicity tests. KBrO3 and NaCl02 were dissolved, and
NaCIO was diluted, in distilled water and administered
orally to animals as their drinking water ad libitum.
The doses chosen for the carcinogenicity tests were as
follows: KBrO3: 500 or 250 ppm for rats of both sexes
and 1000 or 500 ppm for female mice. NaCIO: 1000 or
500 ppm for male and 2000 or 1000 ppm for female rats
and 1000 or 500 ppm for mice of both sexes. NaCIO2:
600 or 300 ppm for rats and 500 or 250 ppm for mice,
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FIGURE 4. Detail of large adenocarcinoma of the kidney showing solid and tubular growth pattern. Hematoxylin and eosin (H&E) X110.
of both sexes. Control animals were given distilled
water, and all animals were allowed free access to basal
diet (CRF1, Charles River). All three compounds were
given continuously to rats and mice for at least 104 and
78 weeks, respectively, except in the case of the test
for NaCIO2 in rats, which was terminated prematurely
in week 85. The animals were observed daily. Dead
animals and those found moribund were autopsied im-
mediately. Consumption of water and body weights
wererecorded. Attermination ofthe tests, allsurviving
animals were anesthetized by ether inhalation to collect
blood for hematologic and serum biochemical analysis.
At necropsy, organs were grossly examined, excised,
and weighed. They were stained with hematoxylin and
eosin after routine histological processing. After de-
tailed microscopic examination, the data were statisti-
cally analyzed using either the chi-square test, Fisher's
exact probability test, or Student's t-test.
Results
Carcinogenicity Tests on KBrO3
Rat. In males given 500 ppm ofKBrO3 (4), the dose
was reduced to 400 ppm atweek60because of amarked
inhibition ofbody weight increase (Fig. 1). No apparent
inhibition ofbodyweight increase occurred in either sex
given 250 ppm. The survival curves ofmale and female
Table 1. Incidence of renal cell tumors in rats given KBrO3.
Group Mean induction Earliest renal No. (%) of rats bearing
KBrO3 dose, Effective no. of time ± SD, cell tumor, Renal cell Adeno-
Sex ppm ratsa weeks weeks tumors carcinomas Adenomas
Male 500 52 88.9 ± 18.9 14 46(88)* 44(85)* 5(10)t
250 53 103.7 ± 9.1 77 32(60)* 24(45)* 1O(19)t
0 53 111.0 ± 0 111 3 (6) 3 (6) 0 (0)
Female 500 49 107.9 ± 5.6 85 39(80)* 36(69)* 9(17)t
250 50 107.6 ± 5.8 89 28(56)* 21(40)* 8(15)t
0 47 - 0 (0) 0 (0) 0 (0)
aMales and females surviving longer than 14 and 85 weeks, respectively, when the first renal cell tumors were found.
*p<O.001.
tp<0.01
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Table 2. Incidence of mesotheliomas in male rats given KBrO3.
KBrO3 Mean induction Earliest No. (%) of rats
dose, Effective time ± SD, mesothelioma with
ppm no. ofratsa weeks found, weeks mesotheliomas
500 46 91.0 ± 10.7 73 28(59)*
250 52 95.0 ± 14.4 72 17(33)t
0 53 98.8 ± 12.1 80 6(11)
aMales surviving longer than 72 weeks when the first mesothelioma
was found.
*p<O.OO1.
tp<0.05.
rats given KBrO3 for 110 weeks are shown in Figure 2.
Dead or moribund rats appeared earlier among males
given 500 ppm. For females, the survival curves of
treated and control groups were very similar. All sur-
viving animals were sacrificed in week 111. No signifi-
cant differences in waterintake were apparentbetween
treated and controlgroups. Dailyintakes ofKBrO3 (mg/
kg body weight/day) were, in males, 27.7 and 12.5 and,
in females, 25.5 and 12.5, in high- and low-dose groups,
respectively.
For detailed histopathologic examination for kidney,
10-15 step-serial sections were made per kidney in this
study. As a result, high incide
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FIGURE 7. Survival curves for male and female rats given NaClO.
nces ofrenal cell tumors in KBrO3-treated rats of both sexes were noted. Most
renal cell tumors were microscopic in size, although
some were visible as round yellowish-white or grayish
projections from the renal cortex (Fig. 3). Histologi-
cally, renal cell tumors were classified as adenocarci-
male nomas and adenomas, the former appearing irregularly
-~ contoured as if several small nodules were aggregated.
--/ They were mostly localized in the cortical areas and
exhibited solid growth patterns, although in some cases
trabecular, tubular, or papillary patterns were also ob-
served (Fig. 4). Apparent infiltrative growth was seen
in caseswithgrosslylargetumors. Thetumorcellswere
_______ found to have either clear cytoplasm (clear cell), eosi-
---- 00--SOOppM nophilic granular cytoplasm (granular cell), or homog-
-OOOppm enously basophilic cytoplasm (dark cell). Adenomas ap-
peared as oval, solitary nodules consisting of closely
packed polygonal cells. They were well circumscribed so 80 100 with thin fibrous capsules. Besides these distinct neo-
plastic lesions, dysplastic foci, considered preneoplastic
mice given KBrO3. changes, were frequently observed. Table 1 shows the
incidences of adenocarcinomas and adenomas and their
combined incidences as renal cell tumors. Renal cell
- - ,.. tumors developed in 46 (88%), 32 (60%), and 3 (6%) of
the males and 39 (80%), 28 (56%), and 0 (0%) of the
females given 500, 250, and 0 ppm of KBrO3, respec-
tively. The percentages ofanimals developingrenal cell
tumors among animals treated with KBrO3 were 74.3%
(78/105) males, 67.7% (67/99) females, and 71.1% (145/
200) all animals. Incidences of renal cell tumors in
treated groups ofboth sexes were significantly different
from those in control groups (p<.001). Also, the inci-
._._._._.... ._... dences ofadenocarcinomas and adenomas ofthe kidney
60 so 1004 in both sexes were significantly different at levels of
p<0.001 and p<0.01, respectively.
In addition, high incidences of tumors of the perito-
mice given KBrO3. neum, all diagnosed as mesotheliomas, were observed
ob
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m
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Table 3. Histopathologic diagnoses of tumors occurring at relatively high incidence in rats given KBrO3.
Effective no. of rats (examined histologically)
No. (%) oftumor-bearing rats
Pituitary
Adenoma (chromophobic)
Ear duct
Squamous cell carcinoma
Mammary gland
Fibroma
Fibroadenoma
Adenoma
Adenocarcinoma
Thyroid
C-cell adenoma
C-cell adenocarcinoma
Follicular adenoma
Follicular adenocarcinoma
Papillary adenoma
Papillary adenocarcinoma
Pancreas
Acinar cell adenoma
Insuloma
Malignant insuloma
Adrenal
Pheochromocytoma
Malignant pheochromocytoma
Cortical adenoma
Ganglioneuroma
Ganglioneuroblastoma
Lung
Adenoma
Adenocarcinoma
Large intestine
Adenoma
Adenocarcinoma
Fibrosarcoma
Liver
Neoplastic nodule
Hepatocellular carcinoma
Cholangioma
Testis
Interstitial cell tumor
Uterus
Endometrial stromal polyp
Adenoma
Fibrosarcoma
Spleen
Leukemia (mononuclear cell)
Malignant hemangioendothelioma
Skin
Squamous cell papilloma
Squamous cell carcinoma
Preputial gland/clitoral gland
Adenoma
Squamous cell carcinoma
in males treated with KBrO3 (Table 2). The incidences
of mesotheliomas in male rats given 500 or 250 ppm
were significantly different from that in controls, re-
spectively, at p<0.001 and p<0.05 levels.
Table 3 summarizes the histopathologic diagnosis of
tumors occurring atrelativelyhighincidences in various
organs other than in the kidney and peritoneum. The
incidences oftumor-bearing animals were very high in
both control and treated groups of both sexes. This
phenomenon resulted from the high incidences of tu-
mors of kidney, testis, peritoneum, thyroid, pituitary,
mammary gland, and spleen.
Nonneoplastic renal tubular lesions occurring in
KBrO3-treated rats included variousdegenerative, nec-
rotic, and regenerative changes. Hyaline cast in the
tubular lumen, and hyaline droplets, eosinophilic bod-
ies, and brown pigments in the tubularepithelium were
also commonly observed. Biochemical analysis of the
500 ppm
KBrO3
52
52 (100)
3 (6)
3
3 (6)
3
3 (6)
2
1
15 (29)
2
2
5
1
5
1 (2)
1
9 (17)
8
1
6 (12)
6
3 (6)
3
6 (11)
5
1
52 (100)
52
11 (21)
11
5 (8)
1
2 (4)
2
Male
250 ppm
KBrO3
53
53 (100)
8 (15)
8
7 (13)
4
3
14 (26)
S
2
2
5
2 (4)
2
7 (13)
7
5 (10)
4
1
2 (4)
2
7 (13)
5
1
1
50 (94)
50
12 (23)
121
1 (2)
5 (9)
5
0 ppm
53
53 (100)
12 (23)
12
14 (26)
4
7
3
10 (21)
7
2
1
7 (13)
1
4
2
6 (12)
6
5 (10)
4
1
2 (4)
2
52 (98)
52
9 (17)
9
2 (4)
1
3 (6)
2
1
500 ppm
KBrO8
52
43 (83)
12 (23)
12
2 (4)
1
1
12 (23)
4
1
2
5
1 (2)
1
1 (2)
1
3 (6)
2
1
3 (6)
1
2
2 (4)
2
4 (8)
2
1
1
12 (23)
11
1
3 (6)
3
Female
250 ppm
KBrO3
52
48 (92)
15 (29)
15
1 (2)
1
6 (12)
3
3
10 (19)
6
1
1
2
2 (4)
1
1
4 (8)
4
3 (6)
2
1
1 (2)
1
4 (8)
3
1
14 (27)
14
1 (2)
1
4 (8)
4
0 ppm
52
44 (85)
21 (40)
21
1 (2)
1
3 (6)
1
2
3 (6)
2
1
3 (6)
2
1
9 (17)
4
3
1
1
1 (2)
1
2 (4)
2
10 (19)
9
1
1
13 (25)
13
2 (4)
2
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Table 4. Histopathologic diagnoses of tumors occurring in female mice given KBrO3.
Female
1000 ppm 500 ppm
KBrO3 KBrO3 0 ppm
Effective no. of mice 47 48 46
No. (%) oftumor-bearing mice 22 (47) 16 (33) 15 (33)
Pituitary 1 (2) 3 (7)
Adenoma 1 3
Harderian gland 2 (4)
Adenoma 2
Mammary gland 1 (2) 1 (2)
Adenocarcinoma 1 1
Lung 8 (17) 3 (6) 3 (7)
Adenoma 5 1 2
Adenocarcinoma 1 2 1
Squamous cell carcinoma 2
Forestomach 2 (4)
Squamous cell carcinoma 2
Duodenum 1 (2)
Epithelial polyp 1
Liver 6 (13) 3 (6) 3 (7)
Adenoma 3 3
Hemangioma 1
Carcinoma 2 3
Pancreas 1 (2)
Adenoma 1
Spleen 3 (6) 1 (2)
Hemangioma 1 1
Hemangiosarcoma 2
Lymph node 7 (15) 4 (8) 4 (9)
Lymphoma 7 4 4
Kidney 2 (4) 1 (2)
Adenoma 1 1
Adenocarcinoma 1
Adrenal 1 (2)
Adrenocortical tumor 1
Uterus 3 (6) 1 (2)
Squamous polyp 1 1
Leiomyoma 1
Endometrial sarcoma 1
Abdominal cavity 1 (2)
Fibroma 1
Skin 1 (2) 1 (2) 1 (2)
Fibrosarcoma 1 1 1
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FIGURE 9. Survival curves for male and female mice given NaCIO.
serum revealed significant decreases in glutamic-py-
ruvic transaminase, the albumin-to-globulin ratio,
serum potassium, and cholinesterase in females given
500 ppm KBrO3. Also, slightly increased levels ofblood
urea nitrogen were observed in males and females
treated with KBrO3.
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FIGURE 11. Survival curves formale and female ratsgiven NaClO2.
Mouse. Treatment of male mice was discontinued
during this study (S. Takayama, unpublished data) be-
cause ofsevere fighting phenomena. Female mice were
given KBrO3 at doses of 1000 or 500 ppm for 78 weeks
and thereafter given tap water for 26 weeks. All sur-
vivors were sacrificed at week 104. Although body
weightincreasewasmarkedlyinhibitedinthehigh-dose
group (Fig. 5), the survival curves were comparable,
and sufficient numbers of animals survived for 104
weeks in all three groups (Fig.6). Daily intakes of
KBrO3 (mg/kg body weight/day) were 119.8 and 56.5
given at 1000 and 500 ppm, respectively.
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Results ofhistologic examination oftumors are shown
in Table 4. No significant differences in the incidences
of tumor-bearing animals were apparent between
treated and control groups. Although relatively high
incidences of lung, liver and lymph node tumors were
observed in the high-dose group, the incidences ofthese
tumors were not significantly different from those of
controls.
Carcinogenicity Tests on NaCIO
Rat. In this test (M. Takahashi, unpublished data),
NaClO was given orally at concentrations of1000 or 500
ppm and 2000 or 1000 ppm, respectively, to males and
females for 104 weeks. The rats were thereafter given
distilledwater, and allsurvivors were sacrificed atweek
112. The survival ratios at week 104 were very high,
ranging from 80% to 70%, in all groups of both sexes
(Fig. 7). Dose-dependent inhibition of body weight in-
crease was observed in both male and female rats (Fig.
8). Drinking water intakes were comparable among all
groups.
All three groups demonstrated relatively high inci-
dences oftumors ofthe testis, pituitary, thyroid, lung,
pancreas, uterus, mammary gland, spleen, and subcu-
taneous tissue (Table 5). Histologically, chromophobic
adenomas of the pituitary, adenomas and adenocarci-
nomas of C-cells of the thyroid, adenomas of the lung,
insulomas of the pancreas, fibroadenomas of the mam-
mary gland, and mononuclear cell leukemias were iden-
tified in both males and females. Also, high incidences
of interstitial cell tumors of the testis and fibromas in
subcutaneous tissue in males and endometrial polyps of
the uterus in females were observed. However, signif-
icant compound-related increases in tumor incidences
werenotfoundinanyorgans oftreatedanimalsofeither
sex. Incidences ofnonneoplastic lesions, such as chronic
nephropathy in treated males and granulomatous
changes in the liver of treated females, were signifi-
cantly decreased. Hematologic and serum biochemical
analyses did not reveal significant dose-related changes
in any parameters in either sex treated with NaCIO.
Mouse. Groups of50 male and 50 female mice were
given NaClO at doses of 1000 or 500 ppm for 103 weeks
(S. Asahina, unpublished data). However, control
groups consisted or 73 males and 72 females inthis test.
All survivingmice were sacrificed atweek 106, atwhich
timethesurvivalrateswere74%, 78%, and66%inmales
and 78%, 80%, and 78% in females, respectively, for
high-dose, low-dose, and control groups (Fig. 9). Dose-
related reductions in body weight increase occurred in
both sexes (Fig. 10). Total intakes (g/mouse/103 wks)
ofNaClO were 3.02 and 1.81 in males and 2.86 and 1.47
in females, respectively, in high- and low-dose groups.
Tumors occurring with relatively high incidences are
listed in Table 6. Combined incidences ofleukemias and
malignant lymphomas and of adenomas and adenocar-
cinomas of the lung were very high in all groups for
both sexes. Also, high incidences of hyperplastic nod-
ules and hepatocellular carcinomas ofthe liver in males
of all groups were noteworthy. However, statistically
significant differences were not observed in tumor in-
cidences for any organs of treated animals.
Carcinogenicity Tests on NaC102
Rat. This study (Y. Hiasa, unpublished data) was
prematurely terminated at week 85 because of wide-
spread Sendai viralinfection in allgroups, necessitating
immediate sacrifice ofall survivors. At necropsy, pneu-
monias were found in all animals, and an abscess ofthe
lung had developed in some cases. Percentages of sur-
vivors at week 85 were 86%, 60%, and 68% in males
and 100%, 88%, and 94% in females, respectively, in
high-dose (600 ppm), low-dose (300 ppm), and control
groups (Fig. 11). Body weight increase was inhibited in
a dose-dependent manner in both males and females
(Fig. 12). Drinking water intake in treated animals was
slightly lowerthanthat incontrol animalsofboth sexes.
Daily consumption ofNaCl02 (mg/kg body weight/day)
was 32.1 and 18.0 in males and 40.9 and 28.3 in females,
respectively, for high- and low-dose groups.
No statisticallysignificant differences intheincidence
oftumor-bearing animals were observedbetween treat-
ment and control groups of either sex. Incidences of
tumors in several organs were appreciable (Table 7),
i.e., C-cell adenomas of the thyroid, pheochromocyto-
mas of the adrenal, and interstitial cell tumors of the
testis in males, and chromophobic adenomas of the pi-
tuitary and endometrial polyps ofthe uterus in females.
However, no statistically significant differences in the
rates of tumor development in any organs were ob-
served between NaCIO2-treated and control animals of
80 Female
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Table 5. Histopathologic diagnoses of tumors occurring at relatively high incidence in rats given NaClO.
1000 ppm
NaClO
50
50 (100)
4 (8)
4
7 (14)
1
1
1
4
3 (6)
2
1
10 (20)
6
3
1
2 (4)
2
Effective no. of rats
No. (%) oftumor-bearing rats
Pituitary
Adenoma (chromophobic)
Ganglioneuroma
Thyroid
Follicular adenoma
Follicular adenocarcinoma
Papillary adenoma
Papillary adenocarcinoma
C-cell adenoma
C-cell adenocarcinoma
Adrenal
Cortical adenoma
Pheochromocytoma
Malignant pheochromocytoma
Lung
Adenoma
Adenocarcinoma
Squamous cell carcinoma
Giant cell carcinoma
Pancreas
Insuloma
Liver
Adenoma
Hepatoma
Cholangioma
Malignant fibrous histiocytoma
Testis
Interstitial cell tumor
Uterus
Endometrial stromal polyp
Adenoma
Adenocarcinoma
Myoma
Fibroma
Malignant histiocytoma
Mammary gland
Adenoma
Fibroadenoma
Adenocarcinoma
Spleen
Leukemia
Hemangioma
Hemangioendothelioma
Subcutaneous tissues
Fibroma
Male
500 ppm
NaClO
50
49 (98)
0 ppm
49
49 (98)
2000 ppm
NaClO
50
38 (76)
Female
1000 ppm
NaClO
50
42 (84)
0 ppm
50
45 (90)
7 (14) 4 (8) 20 (40) 26 (52) 22 (44)
7 4 20 26 21
11 (22)
1
7
3
2 (4)
2
4 (8)
4
4 (8)
4
3 (6)
1
1
1
49 (98) 48 (96)
49 48
4 (8)
4
4 (8)
1
2
1
11 (22) 11 (22)
10 11
1
7 (14)
6
4 (8)
3
7 (14)
5
2
10 (20)
3
7
6 (12)
6
6 (12)
6
1 (2)
1
49 (98)
49
7 (14)
6
1
8 (16)
7
1
10 (20)
9
3 (6)
3
1 (2)
1
1 (2)
1
2 (4)
2
14 (28)
6
1
6
1
3 (6)
2
1
2 (4)
2
2 (4)
2
8 (16)
1
1
5
1
4 (8)
2
2
2 (4)
2
1 (2)
1
12 (24)
7
3
1
1
1 (2)
1
1
3 (6)
3
4 (8)
3
1
2 (4)
2
9 (18)
5
2
2
11 (22)
2
8
1
6 (12) 9 (18)
6 8
1
either sex. Serum biochemistry analysis revealed that
levels ofglutamic oxaloacetic transaminase in the liver
were significantly decreasedinthehigh-dose males. He-
matalysis and urinalysis revealed no significant changes
in blood or urine.
Mouse. Miceintreatment groups ofboth sexes were
given NaClO2 at concentrations of 500 or 250 ppm for
85 weeks, at which time all survivors were sacrificed
(Y. Konishi, unpublished data). Dead or moribund male
mice were found during the experiment earlier in con-
trol groups than in the treated groups (Fig. 13) because
of severe fighting. Survival percentages at the end of
the study were 86%, 94%, and 70% in males and 100%,
100%, and 94% in females, respectively, in high-dose,
low-dose, and control groups. However, body weight
increases were comparable among all groups of either
sex (Fig. 14).
As shown in Table 8, the incidences of liver tumors
were higher in treated males than in control males.
These tumors were histologically diagnosed as hyper-
plastic nodules or hepatocellular carcinomas. The com-
bined incidences ofthese tumors were significantly dif-
ferent in males of the low-dose group (p < 0.05). The
incidences ofhyperplastic nodules ofthe liver in males
were significantly higher in both high- and low-dose
groups (p < 0.05), although the incidences did not ex-
hibit a dose-related effect. Also, the combined inci-
dences of adenomas and adenocarcinomas and that of
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Table 6. Histopathologic diagnoses oftumors occurring at relatively high incidence in mice given NaCIO.
1000 ppm
NaClO
50
40 (80)
Effective no. of rats
No. (%) oftumor-bearing mice
Pituitary
Adenoma
Hematopoietic organs
Leukemia/Malignant lymphoma
Spleen
Hemangioma
Hemangiosarcoma
Liver
Hyperplastic nodule
Hepatocellular carcinoma
Hemangioma
Lung
Adenoma/adenocarcinoma
Uterus
Endometrial stromal polyp
Adenocarcinoma
Endometrial stromal sarcoma
Leiomyoma
Leiomyosarcoma
Hemangioma
Hemangiosarcoma
Mammary gland
Fibroadenoma
Adenocarcinoma
Adenoacanthoma
Harderian gland
Adenoma
Skin and subcutis
Fibrosarcoma
Fibrous histiocytoma
Malignant fibrous histiocyt.
Angiofibroma
Hemangioma
Leiomyoma
Rhabdomyosarcoma
Malignant neurofibroma
Unclassified
3 (6)
3
3 (6)
3
24 (48)
7
15
2
9 (18)
9
5 (10)
5
2 (4)
1
1
Male
500 ppm
NaClO
50
39 (78)
10 (20)
10
1
27 (54)
10
17
9 (18)
9
4 (8)
4
2 (4)
0 ppm
73
53 (73)
1000 ppm
NaClO
50
26 (54)
13 (18) 8 (16)
13 8
3 (4) 2 (4)
1 1
2 1
31 (42) 3 (6)
5 2
24 1
2
10 (14) 5 (10)
10 5
1 (2)
1
1 (2)
1
1
5 (14) 7 (14)
5 7
4 (5) 1 (2)
1
Female
500 ppm
NaClO
50
34 (68)
0 ppm
72
42 (58)
5 (10) 1 (1)
5 1
12 (24) 21 (29)
12 21
2 (4)
2
4 (8) 9 (13)
3 5
1 4
6 (12) 7 (10)
6 7
6 (12) 3 (4)
2
1 1
1
1 -
1
1
1
1 (2) 2 (3)
1
1
1
3 (6) 9 (13)
3 9
1 (2) 2 (3)
- 1 - --1
1
1
1
- 1 - - 1
1 1
1
Table 7. Histopathologic diagnoses of tumors occurring in rats given NaCIO2.
Effective no. of rats
No. (%) of tumor-bearing rats
Pituitary
Adenoma
Thyroid
C-cell adenoma
Adrenal
Pheochromocytoma
Testis
Interstitial cell tumor
Uterus
Endometrial polyp
Adenocarcinoma
Mammary gland
Fibroma
Subcutis
Fibroma
Male
600 ppm 300 ppm
NaClO2 NaClO2
43 30
36 (83) 23 (76)
3 (7) 2 (7)
3 2
6 (14) 3 (10)
6 3
7 (16) 3 (10)
7 3
29 (67) 22 (73)
29 22
1 (2)
1
1 (2)
1 -
230
0 ppm
34
28 (82)
3 (9)
3
3 (9)
3
9 (27)
9
24 (71)
24
600 ppm
NaClO2
50
21 (42)
13 (26)
13
3 (6)
3
7 (14)
7
Female
300 ppm
NaClO2
44
14 (31)
8 (18)
8
1 (2)
1
5 (11)
5
0 ppm
47
15 (31)
10 (21)
10
6 (13)
1
1CARCINOGENICITY OF HALOGEN SALTS
50j
40j
30
Male r
20+
0'
- 10*
I--
cx
o 0
m60
0
Oppm
----- 250ppm
SOOppm
Female
401
301
20
10'
0 20 40 60 80
weeks
FIGURE 14. Growth curves for male and female mice given NaClO2.
adenomas ofthe lung were significantly higher in males
ofthe high-dose group (p < 0.05). Relativelyhigh tumor
rates were observed for malignant lymphomas and/or
leukemias and adenomas ofthe Harderian gland in both
sexes, and fortumors ofthe liverandthe lunginfemales
ofall groups. Ofthese, the incidences ofmalignant lym-
phomas and/or leukemias in the high-dose female group
were smaller by a statistically significant margin.
Discussion
The design and conduct of the long-term assays de-
scribed in this paper were considered adequate accord-
ing to recent guidelines for carcinogenicity testing and
evaluation of data (1-3, 5, 6), although the test on
KBrO3 in mice was carried out onlyin females, and that
on NaClO2 in rats of both sexes was stopped at week
85 because ofinfection. As a result, KBrO3 was shown
to have carcinogenic effects in rats of both sexes.
NaC1O2 was negative in rats, although it generated
equivocal data in male mice. However, no evidence of
carcinogenicity was apparent for NaClO in both rats
and mice of either sex.
KBrO3 induced renal cell tumors in both male and
female rats and mesotheliomas of the peritoneum in
male rats when it was given orally at doses of 500 or
250 ppm for 110 weeks (4,7). The incidences of both
tumors were significantly elevated and showed dose-
response relationships. In the study of KBrO3 using
female mice, on the other hand, no statistically signif-
icant differences in the incidences of any tumors were
observed between treatment and control goups. Kidney
tumors found in this study were one adenocarcinoma
and one adenoma in the high-dose group and one ade-
noma in the control group. Long-term oral administra-
tion of KBrO3 to male mice of three strains (BDF1,
CDF1 and B6C3F1) is currently underway at a dose of
750 ppm, based on the fact that kidney tumor incidence
in mice is higher in males than in females (8).
Table 8. Histopathologic diagnosis of tumors occurring in mice given NaCIO2.
Male Female
500 ppm 250 ppm 500 ppm 250 ppm
NaClO2 NaClO2 0 ppm NaClO2 NaClO2 0 ppm
Effective no. ofrats 43 47 35 50 50 47
No. (%) oftumor-bearing mice 22 (51) 27 (57) 14 (40) 13 (26) 17 (34) 14 (30)
Liver 17 (40) 22 (47)* 7 (20) 6 (12) 5 (10) 5 (11)
Hyperplastic nodule 11 (26)* 14 (30)* 3 5 3 5
Hepatocellular carcinoma 6 8 4 1 1
Hemangioma - 1
Lung 7 (16)* 3 (6) 2 (4) 2 (4) 3 (6)
Adenoma 5 (12)* 2 2 1 3
Adenocarcinoma 2 1 1
Malignant lymphoma/leukemia 1 (2) 2 (4) 4 (11) 1 (2)* 5 (10) 7 (15)
Harderian gland 1 (2) 3 (6) 1 (3) 4 (8) 4 (8) 2 (4)
Adenoma 1 3 1 4 4 2
Spleen 1 (3) 1 (2)
Hemangioma - 1 1
Subcutis 2 (5) 2 (4)
Fibrosarcoma 1 2
Malignant fibrous histiocytoma 1
Pituitary - 2 (4)
Adenoma - 2
Thyroid - 1 (2)
Follicular adenoma - - 1
Ovary 1 (2)
Papillary adenoma 1
*p < 0.05 (Fisher's exact probability test).
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Table 9. Dose-response studies for renal lesion development after oral administration of KBrO3 for 104 weeks in male F-344 rats.
Dysplastic foci (DF) Renal cell tumors (RCT)
Dose of KBrO3, Effective no. of Incidence of DF Total no. No. of DF per rat Incidence of Total no. No. of RCT
ppm rats (%) of DF ± SD RCT (%) of RCT per rat
500 20 19(95)a 146 7.30 ± 5.60 9(45)* 25 1.25
250 20 19(95)a 84 4.20 ± 2.40 5(25)t 5 0.25
125 24 12(50)a 19 0.79 ± 1.04 5(21)t 5 0.21
60 24 6(25)b 8 0.33 ± 0.62 1(4) 1 0.04
30 20 5(25)b 5 0.25 ± 0.43 0 0 0
15 19 1(5) 1 0.05 0.22 0 0 0
0 19 0 0 0 0 0 0
*p < 0.001.
tp < 0.05 (Fisher's exact probability test).
Table 10. Results of mutagenicity tests on KBrO3, NaClO, and
NaCI02.8
Test KBrO3 NaClO NaCl02
Ames test Positive Positive Positive
DNA repair test Negative Positive Not tested
Chromosome aberration test Positive Positive Positive
Micronucleus test Positive Negative Positive
aData taken from references (30-32) or supplied as personal com-
munication from Dr. M. Ishidate, Department of Mutagenesis, Na-
tional Institute ofHygienic Sciences.
Long-termfeedingstudiesforKBrO3inGreatBritain
have been reported (9, 10). Abasalbread diet prepared
from untreated flour or from flour treated with 50 or 75
ppm of KBrO3 was given to rats (9) and mice (10) for
104 and 80 weeks, respectively. No evidence ofcarcin-
ogenicity or chronic toxicity was observed in either ex-
periment. The discrepancy in results can be explained
by the finding that almost all KBrO3 added to flour at
normal food additive levels is converted to potassium
bromide (KBr) during the normal British baking pro-
cess, and the amount ofKBrO3 is negligible in the final
products (11,12). Therefore, commercial bread supple-
mented with KBrO3 was found to be noncarcinogenic to
rats and mice in the British studies. In contrast, our
test demonstrated positive potential carcinogenicity of
KBrO3, which itself is very stable in water, in rats of
both sexes when administered in their drinking water.
Recently, long-term dose-response studies on this
chemical have been completed (Y. Kurokawa, unpub-
lished data). Male F344 rats were given KBrO3 orally
for 104 weeks at concentrations of500, 250, 125, 60, 30,
or 15 ppm (Table 9). Statistically significant increases
were observed in the incidences ofrenal cell tumors in
rats treated with > 125 ppm. In addition, incidences of
dysplastic foci, considered to bepreneoplastic lesions of
renal cell tumors (13,14), were significantly higher in
rats treated with > 30 ppm. The virtually safe dose
(VSD) ofKBrO3 for renal cell tumors was estimated by
theprobitmodelwithindependentbackground(S. Aoki,
unpublished data). The VSD at risk levels of 106 and
10-8 was 0.950 and 0.302 ppm, respectively (p=0.877).
To determine further species differences in the car-
cinogenicity of KBrO3, male Syrian golden hamsters
were treated orally for 89 weeks (Y. Kurokawa, un-
published data). Inthisstudy, nostatisticallysignificant
differences were observed in the incidences of tumors
in any organs. However, the rates ofrenal cell tumors
were 11% (2/19), 20% (4/20), 6% (1/17), 0% (0/19), and
0% (0/20), respectively, in groups given 2000, 500, 250,
125, or 0 ppm. Although the incidences were relatively
low and were not statistically different, the results
seemed to indicate the potential for KBrO3 to induce
renal cell tumors in male hamsters, inasmuch as the
incidences of spontaneous kidney tumors were ex-
tremely low in this rodent species (15-17).
The promotingeffectofKBrO3wasalsoinvestigated.
KBrO3 given orally at a concentration of 500 ppm was
found to have a promoting effect on renal, but not on
liver, tumorigenesis, wheninitiated withN-ethyl-N-hy-
droxyethylnitrosamine (EHEN) in male F344 rats (14).
Subsequently, dose-response studies in two-stage renal
carcinogenesis were undertaken to ascertain whether a
threshold level of KBrO3 treatment exists for its pro-
motingactivity (18). Male F344ratsweretreated orally
at doses of500, 250, 125, 60, 30, or 15 ppm for24 weeks
after initiation with EHEN. The results showed that
the mean numbers of kidney dysplastic foci were sig-
nificantly increased in a dose-related manner when
KBrO3 was given at doses of > 30 ppm. Therefore, the
threshold level for enhancing renal tumorigenesis
seemed to lie between 30 and 15 ppm. The potential
enhancing effect of KBr was also tested in this study,
with the resultthatitwas considered negativeforrenal
carcinogenesis (18).
From studies on carcinogenicity and on promoting
effects, we concluded that KBrO3 possessed both ini-
tiating and promoting activities, the characteristics of
a complete carcinogen, for development of renal cell
tumors in rats. In contrast, KBrO3 exhibited neither
promoting nor complete carcinogenic activities for skin
carcinogenesis (19).
Several experiments were conducted to elucidate the
mechanism of carcinogenic action of KBrO3 (Y. Kuro-
kawa, unpublished data). In acute toxicity studies,
KBrO3 induced a dose-dependent increase in lipid per-
oxidation in the kidney. Survival times after a single
intravenous administration ofKBrO3were extended by
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pretreatment with glutathione in male F344 rats. Ul-
trastructurally, extensive damage to the mitochondria
of the renal tubular epithelium was observed. The ap-
pearance ofmultiple eosinophilicbodiesinthecytoplasm
of proximal renal tubules in KBrO3-treated rats was
noteworthy as a nonneoplastic change in the kidney.
These droplets were strongly stained with eosin and
were positive with the Azan stain, but were negative
for the periodic-acid Schiff stain (20).
In the test ofNaClO2, no evidence ofcarcinogenicity
was apparent in rats of either sex. On the other hand,
marginal increases were observed in the incidences of
liver and lung tumors in male mice given NaClO2.
Namely, statistically significant increases were found
inthecombinedincidences ofhyperplastic nodules (HN)
and hepatocellular carcinomas (HCC) of the liver in a
low-dose group, and adenomas and adenocarcinomas of
the lung in a high-dose group in males (both p,<0.05).
It should be mentioned, however, that males in the
control group died spontaneously, earlier than treated
males in this study because ofsevere fighting (Fig. 13)
and were not included in the effective numbers for his-
topathologicexamination. Ontheotherhand, respective
incidences of HN and HCC of the liver were 27.8%
(range, 22-33%) and 20.1% (range, 8-23%) in 194 un-
treated B6C3F1 males in earlier bioassays in our pro-
gram (S. Fukushima, unpublished data). Also, the in-
cidences ofadenomas and adenocarcinomas ofthe lung
were 9.8% (range, 6-16%) and 5.7% (range, 2-8%), re-
spectively, in the same controls. Note that, although
statistically elevated over those ofconcurrent controls,
the rates of HN of the liver in the high-dose (25.6%)
and low-dose (29.8%) groups and that oflung adenomas
inthe high-dose group (11.6%) wereallwithintherange
ofhistorical control data forourprogram as well as that
ofthe National ToxicologyProgram (21). Weconcluded,
threrefore, especially since significant increases were
observed only in the incidences ofbenign tumors, that
theresults ofthe carcinogenicity testonNaClO2in mice
were inconclusive under the conditions ofthis study.
Several toxicological studies have reported results of
tests onchlorine andchloritebecause oftheunavoidable
human exposure to these substances in drinking water
after disinfection (22-26). The potential toxicity ofhy-
pochlorous acid (HOCl) when orally administered to
male Sprague-Dawley rats for 12 months at concentra-
tions of 100, 10, or 1 ppm was investigated (26). Sig-
nificant increases were observed in glutathione levels
and osmotic fragility ofthe erythrocytes. Redblood cell
count and hematocrit were significantly decreased.
Also, incorporation of [3H]thymidine into kidney and
testis nuclei was increased. The results of long-term
oraltreatment withhighly chlorinated watercontaining
100 ppm of free chlorine was reported (27). BDll rats
were given chlorine over their life span in seven con-
secutive generations. No compound-related toxicity or
carcinogenicity was observed. NaClO2 was given to
male Sprague-Dawley rats in their drinking water for
12 months at levels of 100 or 10 ppm (25). Various he-
matologic parameters were affected in the treatment
group similarly to HOCl-treated rats (26). However,
suchhematologic changeswere notobservedinrats and
mice ofboth sexes given NaClO or NaClO2 in our car-
cinogenicity tests and in a subchronic study (28). Al-
though positive promoting activity has been reported
forthe ddN-strain mouse skin with application ofa 10%
solution of NaClO (29), this effect was not found when
a 1% NaCIO solution was applied to SENCAR mouse
skin (19). NaCIO2 painted ata concentration of100 ppm
on SENCARmouse skinwas suspected ofexertingskin
promoting activity (19).
Results of mutagenicity testing of the three com-
pounds are summarized in Table 10 (30-32); all three
gave positive results in three out ofthe four mutagen-
icitytests conducted. Therefore, thesecompoundscould
be classified as highly mutagenic compounds. Nonethe-
less, neither NaClO nor NaClO2 appeared carcinogenic
in our studies, although the carcinogenicity of KBrO3
was clearly demonstrated.
KBrO3, NaClO, and NaCl02 have been used for a
variety of purposes using their oxidizing properties, a
characteristic common to allthree compounds. With re-
spect to the in vivo carcinogenic and promoting actions
ofoxidant chemicals, recent reports on mouse skin car-
cinogenesis deserve mention.
Benzoyl peroxide was shown to be a potent promoter
(33) and a possible complete carcinogen (19) in this sys-
tem and was suspected as a causative agent for skin
cancerin humans (34). Hydrogenperoxide, lauroyl per-
oxide, decanoyl peroxide, cumene peroxide (35, 36),
NaClO (29), and NaClO2 (19) were demonstrated to be
relatively weak as promoters, whereas KBrO3 and am-
moniumpersulfatewereinactive eitherascomplete car-
cinogens or as promoters in mouse skin carcinogenesis
(19). In systems otherthanthe skin, hydrogenperoxide
given orally was found to have carcinogenic potential in
mice by inducing duodenal tumors (37,38) and to have
promoting action by increasing intestinal tumor devel-
opment in rats (39). Although KBrO3 showed a pro-
moting effect in two stage rat renal carcinogenesis
(14,18), no such influence was evident for potassium
chlorate and sodium chlorate given orally at a level of
1% for 24 weeks after initiation with EHEN (Y. Ku-
rokawa, unpublished data).
It seems generally accepted that carcinogenic and
promoting action ofthese compounds both in vivo and
in vitro are caused by various kinds of active oxygen
species, e.g., superoxide, singlet oxygen, hydroxy rad-
ical, and hydrogen peroxide (40-42). From extensive
toxicological studies on oxidant chemicals such as pa-
raquat (43), ozone (44), and NO. (45), it was revealed
that these chemicals could induce lipid peroxidation in
their target organs. Induction oflipid peroxidation and
clastogenic actions are now considered to be the un-
derlying mechanisms of carcinogenic and/or promoting
effects shown by the oxidant chemicals (40, 46). Indeed
KBrO3 increased the levels oflipid peroxide in the kid-
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ney (Y. Kurokawa, unpublished data) and was clasto-
genic in Chinese hamster cells (31). In spite of the ac-
cumulating evidence ofthe role offree oxygen radicals
in in vitro promotion and cell transformation, the num-
ber ofin vivo studies available to support in vitro data
remains insufficient (47). Although the skin seems to be
a suitable target organ for detecting potential carcino-
genic and promoting effects ofoxidants (36), the effects
of these compounds on gastrointestinal organs should
also be tested in view of their local action as skin irri-
tants. The fact that humans are inevitably exposed or-
ally to food additives and to by-products of water dis-
infection having oxidizing characters also emphasizes
the need to test these chemicals for carcinogenic and
promoting effects in organs other than skin.
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